CRISPR breakthrough reverses chemotherapy resistance in lung cancer
On Nov. 17, 2025,In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have…
Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
Despite global decrease, Chagas disease is rising in non-endemic regions
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
WHO publishes new global research agenda to strengthen paediatric clinical trials
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
Steady glucose-monitor use helps blood-sugar control
On Nov. 5, 2025, a large study of adults with type 2 diabetes showed that those who consistently…
MIT researchers invent new human brain model to enable disease research, drug discovery
On Nov. 5, 2025, MIT researchers announced they have developed a new 3D human brain tissue platform, the…
Biotechnology | Disease | FDA | Therapeutics
FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
Wildfire smoke tied to higher risk of preterm birth
On Nov. 4, 2025, a team of scientists led by the University of Washington announced findings published this…
United Therapeutics Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
On Nov. 3, 2025, United Therapeutics, a public benefit corporation, announced the first clinical xenotransplantation in its EXPAND…
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
Artificial Intelligence | Biotechnology | Clinical Research | Diagnostics | Disease | Medical Device | Therapeutics
AI-powered diabetes prevention program shows similar benefits to those led by people
On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…
Biology | Cardiology | Diagnostics | Disease | Environmental | EPA | Neurology | Non-Profit Research | WHO | Women's Health
Nearly 9 in 10 air pollution deaths are from noncommunicable diseases
On. Oct. 23, 2025, Air pollution continues to exacerbate global health, including noncommunicable diseases and dementia, according to…
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
Diagnostics | Disease | FDA | Medicine | Pharmaceutical | Therapeutics
FDA unveils drugs to receive expedited review in support of ‘national priorities’
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis
On Oct. 13, 2025, researchers from Texas A&M University announced they have identified two estrogens, estradiol and estriol,…
Biotechnology | Diagnostics | Disease | FDA | NIH
Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
On Oct. 13, 2025, the U.S. Food and Drug Administration (FDA) announces it has cleared the Elecsys pTau181…
Bristol Myers Squibb Acquires Cell Therapy Portfolio with Acquisition of Orbital Therapeutics for $1.5 billion in cash
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
Pig liver transplant into a living person edges it closer to the norm
On Oct. 9, 2025, Beicheng Sun at Anhui Medical University in China and his colleagues have reported the…
Biotechnology | Disease | Genomics | Oncology
Revolutionary blood test for ME / Chronic Fatigue unveiled
On Oct. 8, 2025, scientists at the University of East Anglia and Oxford Biodynamics announced they have developed a…
Disease | Environmental | WHO
WHO Reports 1 in 5 adults still addicted to tobacco
On Oct. 6, 2025, the World Health Organization (WHO) reported world is smoking less, but the tobacco epidemic…
Bath scientists design peptide ‘switch’ that keeps Parkinson’s protein in its healthy form
On Oct. 6, 2025, Researchers at the University of Bath, in collaboration with the Universities of Oxford and…
the 2025 Nobel Prize in Physiology or Medicine awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
On Oct. 6, 2026, The Nobel Assembly has awarded the 2025 Nobel Prize in Physiology or Medicine to Mary E….
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
First human transplant of kidney modified to have ‘universal’ blood type
On Oct. 3, 2025, scientists have converted the blood type of a donor kidney and transplanted the organ…
Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US
On Sept. 26, 2025, Sanofi US announced a broad expansion of its Insulins Valyou Savings Program by offering…
Biotechnology | Diagnostics | Disease | Neurology | NIH
NIH establishes nation’s first dedicated organoid development center to reduce reliance on animal modeling
On Sept. 25, 2025, the National Institutes of Health (NIH) announced the award of contracts for launching the…
CIRM approves $73 million in awards for discovery research
On Sept. 25, 2025, The California Institute for Regenerative Medicine (CIRM) has approved awarding more than $73 million…
Biolinq Shine™ Granted De Novo Classification by U.S. FDA for the First Fully Autonomous, Needle-Free Glucose Sensor
On Sept. 25, 2025, Biolinq, a pioneering developer of precision multi-analyte biosensors to improve metabolic health, announced the…
Gene therapy appears to slow Huntington’s disease progression
On Sept. 24, 2025, a global clinical trial for a new Huntington’s disease treatment has posted positive results,…